Core Viewpoint - Antu Biology (603658) has announced plans to engage in foreign exchange hedging and apply for a loan to support its operational and developmental needs, reflecting a proactive approach to financial management and risk mitigation. Company Announcements - Antu Biology's board of directors held a meeting on January 20, 2026, where all proposed resolutions, including foreign exchange hedging and loan applications, were unanimously approved [1][2][3] - The company plans to apply for a loan of up to 1.5 billion RMB to support daily operations and development needs, with the loan amount being subject to actual requirements [1][3] - The company intends to use up to 8.9 million USD of its own funds for foreign exchange hedging activities, including forward foreign exchange contracts, foreign exchange swaps, and options, to mitigate exchange rate fluctuation risks [1][2][3]
每周股票复盘:安图生物(603658)拟申请不超15亿元贷款